As<unk>  moderately prolongs QT time, addition of other drugs with this property could increase the risk of a type of abnormal heart rhythm, namely torsades de pointes. No relevant interactions with enzyme inhibitors and inducers are expected.
Lenvatinib
Tucatinib
Neratinib
Fostamatinib
Lapatinib
Ponatinib
Selpercatinib
Infigratinib